Home > Back to Publisher > Report Information

An Evaluation of Product Usage for Molecular Testing within Infectious Diseases

HBS Consulting
August 19, 2004
SKU: HBSC1030140

Abstract Table of Contents Related Reports

An Evaluation of Product Usage for Molecular Testing within Infectious Diseases

The new report by HBS Consulting examines the reality of 221 laboratories and hospitals in 11 European countries and provides you with following information:
• Description of laboratory landscape per country
• the number of performed tests for 47 pathogens
• which products, technologies and manufacturers are used per pathogen
• determine current laboratory equipment that is used for microbiology testing
• Unmet needs
• which tests, technologies and products show the most promising market opportunities in the short to medium term
• market potential in volume per test, technology and country
• regulatory issues per country (legislation, reimbursement)

The study will allow the owner of the information to:
• Assess current market realities in terms of currently performed tests / Used technologies at an unparalleled level of segmentation
• Get detailed knowledge on suppliers of molecular test kits / equipment, (by segmentation criteria)
• Reflect the current situation not only at a specific point in time, but monitor trends over a period of time (both in terms of market participants as well as system types)
• Model market and own sales forecasts on system types based on investment plans of customers
• Reflect the expected behaviour of buyers, not just the expectations of sellers; but by the motivations of buyers.
• Model market forecasts on associated product lines (e.g. PCR Cycler, NAT related devices) based on procedure data
• Make decisions regarding the market entry/marketing strategy

Respondents have been chosen randomly in order to guarantee that the respondents reflect the real market situation. However the definition of the project required the focus on such institutions that perform molecular testing particularly.

Table of Contents (Germany) 1.1 Project Objectives 1.2 Definitions 1.3 German Health Care System and Reimbursement Healthcare System Reimbursement Policies Private Laboratories - EBM Hospital Laboratories Maternity Services IGeL - Individual Health Services 1.4 German Laboratory Landscape 1.5 Respondent Population Germany

2. Infectious Diseases Testing in Clinical Laboratories 2.1 Sexual Transmitted Diseases (STD) Chlamydia Trachomatis Neisseria HIV HCV Group B Streptococcus HSV 2.2 Mycobacteria Mycobacteria Tuberculosis Mycobacteria Avium Mycobacteria - NA Purification 2.3 Atypical Pneumoniae Bordetella Legionella Chlamydia sp. Mycoplasma Pneumoniae 2.4 Cytomegalovirus (CMV) CMV - Qualitative Tests CMV - Quantitative Tests 2.5. Viral Meningitis HSV 1 & 2 Enterovirus West Nile Virus (WNV) Epstein Barr Virus (EBV) VZV 2.6 Respiratory Viruses SARS Adenovirus Influenza A Influenza A&B RSV Parainfluenza 2.7 HPV 2.8 Chronic Meningitis 2.9 Bacterial Meningitis Neisseria Meningitis Haemophilus Influenza Pneumococcae Listeria Enterobacteria 2.10 Tick Born Encephalitis 2.11 Antibiotic Resistant Bacteria MRSA VRE 2.12 Candida

3. Equipment & Purchase 3.1 Current Installations & Financing of Laboratory Equipment Cobas Amplicor, Roche Light Cycler, Roche ABI PRISM, Applied Biosystems RotorGene, Corbett Research Other Cycler Other Devices/Manufacturers 3.2 Budget Resources 3.3 Who is Involved in Purchasing Decisions 3.4 How do Laboratories Purchase 3.5 Criteria Influence a Purchasing Decision 3.6 What are Laboratories Willing to Pay for New Tests?

4. Market Sizes and Market Shares 4.1 Market Volumes for Selected Pathogens STD Mycobacteria Tuberculosis Atypical Pneumonia CMV Viral Meningitis Respiratory Viruses HPV MRSA 4.2 Market Shares

5. Market Trends 5.1 Problems with Molecular Diagnostics 5.2 Expected Growth per Segment 5.4 Drivers for Molecular Diagnostics 5.5 Restraints for Molecular Diagnostics 6. Political Influences 6.1 Changes of Reimbursement Policy 6.2 Influence of the EU IVD Act 9 6.3 Other Growth Areas

An Evaluation of Product Usage for Molecular Testing within Infectious Diseases

Share this report

Other tasks

Research Assistance

Related Markets

Diseases & Conditions Reports

Free Alert Me service